Published in Circ Cardiovasc Interv on October 13, 2009
Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study. Stroke (2012) 1.32
Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden. J Am Soc Nephrol (2015) 1.15
Impact of prediabetic status on coronary atherosclerosis: a multivessel angioscopic study. Diabetes Care (2012) 0.91
Intravascular ultrasound appearance of scattered necrotic core as an index for deterioration of coronary flow during intervention in acute coronary syndrome. Heart Vessels (2011) 0.89
The high-risk thin-cap fibroatheroma: a new kid on the block. Circ Cardiovasc Interv (2009) 0.78
Subtotal Gastrectomy With Billroth II Anastomosis Is Associated With a Low Risk of Ischemic Stroke in Peptic Ulcer Disease Patients: A Nationwide Population-Based Study. Medicine (Baltimore) (2016) 0.77
Plasma Lipoprotein-Associated Phospholipase A₂ Levels Correlated with the Cardio-Ankle Vascular Index in Long-Term Type 2 Diabetes Mellitus Patients. Int J Mol Sci (2016) 0.76
Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients? Cardiovasc Diabetol (2017) 0.75
Numerical study to indicate the vulnerability of plaques using an idealized 2D plaque model based on plaque classification in the human coronary artery. Med Biol Eng Comput (2016) 0.75
A prospective natural-history study of coronary atherosclerosis. N Engl J Med (2011) 10.66
Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med (2010) 3.42
Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation (2008) 3.19
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol (2005) 2.81
Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest (2003) 2.40
The prevalence and outcomes of transradial percutaneous coronary intervention for ST-segment elevation myocardial infarction: analysis from the National Cardiovascular Data Registry (2007 to 2011). J Am Coll Cardiol (2012) 2.31
Chronic total occlusion angioplasty in the United States. JACC Cardiovasc Interv (2009) 2.24
Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel. JACC Cardiovasc Interv (2008) 2.20
Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol (2004) 2.14
Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Interv (2009) 2.03
Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice. Arch Intern Med (2012) 1.89
Quantifying improvement in symptoms, functioning, and quality of life after peripheral endovascular revascularization. Circulation (2007) 1.67
Reporting trends and outcomes in ST-segment-elevation myocardial infarction national hospital quality assessment programs. Circulation (2013) 1.67
Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv (2009) 1.62
Survival benefit with drug-eluting stents in observational studies: fact or artifact? Circ Cardiovasc Qual Outcomes (2011) 1.59
Changes in myocardial ischemic burden following percutaneous coronary intervention of chronic total occlusions. Catheter Cardiovasc Interv (2011) 1.47
Costs of transradial percutaneous coronary intervention. JACC Cardiovasc Interv (2013) 1.47
Compensatory enlargement of the left main coronary artery: insights from the PROSPECT study. Coron Artery Dis (2014) 1.47
Hemorrhagic and ischemic outcomes after bivalirudin versus unfractionated heparin during carotid artery stenting: a propensity score analysis from the NCDR. Circ Cardiovasc Interv (2013) 1.46
Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year. Circ Cardiovasc Interv (2012) 1.46
The utility of ADMIRE-HF risk score in predicting serious arrhythmic events in heart failure patients: incremental prognostic benefit of cardiac 123I-mIBG scintigraphy. J Nucl Cardiol (2014) 1.46
Low-to-moderate alcohol intake and health status in heart failure patients. J Card Fail (2005) 1.44
Tissue characterisation of atherosclerotic plaque in the left main: an in vivo intravascular ultrasound radiofrequency data analysis. EuroIntervention (2011) 1.40
Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation (2003) 1.38
Impact of glomerular filtration rate on clinical outcomes after carotid artery revascularization in 11,832 patients from the CARE registry. Catheter Cardiovasc Interv (2014) 1.38
In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry. Catheter Cardiovasc Interv (2012) 1.38
Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J (2004) 1.38
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol (2002) 1.30
Age, functional capacity, and health-related quality of life in patients with heart failure. J Card Fail (2004) 1.27
Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. JACC Cardiovasc Interv (2011) 1.26
Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry. J Am Coll Cardiol (2012) 1.17
Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes (2010) 1.17
Association between bleeding events and in-hospital mortality after percutaneous coronary intervention. JAMA (2013) 1.08
Relationship between palpography and virtual histology in patients with acute coronary syndromes. JACC Cardiovasc Imaging (2012) 1.04
A comparison of the recovery of health status after percutaneous coronary intervention and coronary artery bypass. Ann Thorac Surg (2002) 1.04
Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleeding. Circ Cardiovasc Qual Outcomes (2010) 1.02
Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry. JACC Cardiovasc Interv (2009) 1.02
Management of hyperglycemia with the administration of intravenous exenatide to patients in the cardiac intensive care unit. Endocr Pract (2013) 1.00
Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry. Circ Cardiovasc Interv (2010) 0.99
Characteristics and clinical significance of angiographically mild lesions in acute coronary syndromes. JACC Cardiovasc Imaging (2012) 0.99
Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR. Heart Rhythm (2014) 0.99
Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2: 3 liraglutide clinical development studies. Diab Vasc Dis Res (2011) 0.98
Pre-procedural estimate of individualized bleeding risk impacts physicians' utilization of bivalirudin during percutaneous coronary intervention. J Am Coll Cardiol (2013) 0.97
Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia. Biol Blood Marrow Transplant (2013) 0.96
Clinical referral patterns for carotid artery stenting versus carotid endarterectomy: results from the Carotid Artery Revascularization and Endarterectomy Registry. Circ Cardiovasc Interv (2011) 0.95
Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR. Circ Cardiovasc Qual Outcomes (2013) 0.94
Hospital percutaneous coronary intervention appropriateness and in-hospital procedural outcomes: insights from the NCDR. Circ Cardiovasc Qual Outcomes (2012) 0.94
Intravascular ultrasound radiofrequency analysis of coronary atherosclerosis: an emerging technology for the assessment of vulnerable plaque. Eur Heart J (2007) 0.92
Relation of hemoglobin A1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease. Am J Cardiol (2003) 0.90
Disparity in drug-eluting stent utilization by insurance type. Am Heart J (2008) 0.90
Limitations to the use of virtual histology-intravascular ultrasound to detect vulnerable plaque. Eur Heart J (2007) 0.89
Steatosis and diastolic dysfunction: the skinny on myocardial fat. J Am Coll Cardiol (2008) 0.89
Pre-procedural risk quantification for carotid stenting using the CAS score: a report from the NCDR CARE Registry. J Am Coll Cardiol (2012) 0.88
Association of coronary artery calcification with hepatic steatosis in asymptomatic individuals. Mayo Clin Proc (2013) 0.88
Comparison of bivalirudin and radial access across a spectrum of preprocedural risk of bleeding in percutaneous coronary intervention: analysis from the national cardiovascular data registry. Circ Cardiovasc Interv (2013) 0.88
Causes of short-term readmission after percutaneous coronary intervention. Circ Cardiovasc Interv (2014) 0.88
Do systemic risk factors impact invasive findings from virtual histology? Insights from the international virtual histology registry. Eur Heart J (2009) 0.86
Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in nondiabetic coronary arteries. Diabetes Care (2008) 0.86
Red blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarction. Int J Cardiol (2012) 0.86
Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry). Am J Cardiol (2007) 0.85
LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial. Pancreas (2014) 0.85
Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005-2008. JACC Cardiovasc Interv (2012) 0.84
Relation between angiographic lesion severity, vulnerable plaque morphology and future adverse cardiac events (from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study). Am J Cardiol (2012) 0.84
The impact of bivalirudin on percutaneous coronary intervention-related bleeding. EuroIntervention (2010) 0.83
Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry. J Am Heart Assoc (2014) 0.83
Suspected acute coronary syndrome patients with diabetes and normal troponin-I levels are at risk for early and late death: Identification of a new high-risk acute coronary syndrome population. Diabetes Care (2006) 0.83
Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry. Circulation (2011) 0.83
Regadenoson pharmacologic stress for myocardial perfusion imaging: a three-way comparison between regadenoson administered at peak exercise, during walk recovery, or no-exercise. J Nucl Cardiol (2012) 0.83
Success rates of percutaneous coronary intervention of chronic total occlusions and long-term survival in patients with diabetes mellitus. Diab Vasc Dis Res (2006) 0.82
Myonecrosis following isolated coronary artery bypass grafting is common and associated with an increased risk of long-term mortality. Eur Heart J (2003) 0.82
The effect of intensive glucose control on all-cause and cardiovascular mortality, myocardial infarction and stroke in persons with type 2 diabetes mellitus: a systematic review and meta-analysis. Diab Vasc Dis Res (2009) 0.82
Indications for percutaneous coronary interventions performed in US hospitals: a report from the NCDR®. Am Heart J (2012) 0.81
Investigation of 95 variants identified in a genome-wide study for association with mortality after acute coronary syndrome. BMC Med Genet (2011) 0.81
Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. Circ Cardiovasc Interv (2011) 0.81
Diabetes mellitus is associated with plaque classified as thin cap fibroatheroma: an intravascular ultrasound study. Diab Vasc Dis Res (2009) 0.81